- Economic Development
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program, Regulation
- Federal government relations and advocacy regarding regulations under the Patented Medicine Prices Review Board (and its impact to drugs for rare diseases), national pharmacare policy and implementation, and the development of a federal strategy for drugs for rare diseases.
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Canadian Institutes of Health Research (CIHR)
Finance Canada (FIN)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Senate of Canada
No government funding was received during the last completed financial year.
Client Contact Information
2201 Bristol Circle
Oakville, ON L6H 0J8
Rebecca Yu, Vice President, Market Access and External Affairs
Parent Company Information
Takeda Canada Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Takeda Canada Inc. is not a coalition.
Person or Organization with a Direct Interest Beneficiary Information
The activities of Takeda Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Takeda Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Public offices held
439 University Ave
Toronto, ON M5G 2H6
Consultant Firm and Address
439 University Ave, Suite 780
Toronto, ON M5G 1Y8